Detalhe da pesquisa
1.
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Blood
; 143(13): 1231-1241, 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38145560
2.
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Blood
; 140(1): 16-24, 2022 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35325065
3.
Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia.
Haematologica
; 108(3): 747-760, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36263840
4.
Access offsets poverty in quest for CAR T cells.
Blood
; 141(6): 558-560, 2023 02 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36757731
5.
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia.
Mol Ther
; 27(1): 272-280, 2019 01 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30391141
6.
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
J Transl Med
; 17(1): 240, 2019 07 24.
Artigo
Inglês
| MEDLINE | ID: mdl-31340822
7.
Reverse translational studies inform dual-targeted CAR T-cell design.
Blood
; 140(5): 409-410, 2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35925644
8.
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies.
Blood
; 130(3): 285-296, 2017 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-28539325
9.
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.
Mol Ther
; 25(9): 2202-2213, 2017 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-28676343
10.
Recent advances in T-cell immunotherapy for haematological malignancies.
Br J Haematol
; 176(5): 688-704, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27897332
11.
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies.
Blood
; 126(8): 983-92, 2015 Aug 20.
Artigo
Inglês
| MEDLINE | ID: mdl-26056165
12.
The earlier the better: timely mitigation of CRS.
Blood
; 134(24): 2119-2120, 2019 12 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31830277
13.
Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant.
Curr Opin Hematol
; 21(6): 476-81, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25159713
14.
Equal opportunity CAR T cells.
Blood
; 129(25): 3275-3277, 2017 06 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28642356
15.
ACT To Sustain: Adoptive Cell Therapy To Sustain access to non-commercialized genetically modified cell therapies.
Transplant Cell Ther
; 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38762057
16.
Primed to Kill: CTV-1 Stimulated Haploidentical Natural Killer Cells for Consolidation of AML.
Biol Blood Marrow Transplant
; 24(8): 1533-1535, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29933070
17.
Targeted cellular therapy for treatment of relapsed or refractory leukemia.
Best Pract Res Clin Haematol
; 36(3): 101481, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37612000
18.
Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 29(3): 165.e1-165.e7, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36592718
19.
Mediport use as an acceptable standard for CAR T cell infusion.
Front Immunol
; 14: 1239132, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37965315
20.
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
J Clin Oncol
; 40(9): 945-955, 2022 03 20.
Artigo
Inglês
| MEDLINE | ID: mdl-34882493